Found: 6
Select item for more details and to access through your institution.
Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/5169278
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer: a meta-analysis of randomized clinical trials.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 180, n. 1, p. 21, doi. 10.1007/s10549-020-05528-2
- By:
- Publication type:
- Article
Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2145934, doi. 10.1001/jamanetworkopen.2021.45934
- By:
- Publication type:
- Article
Effects of Breast-Conserving Surgery and Mastectomy on the Survival of Patients with Early-Stage (T1-2N0-1M0) HER2-Positive Breast Cancer: A Propensity Score-Matched Analysis.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 511, doi. 10.1159/000534856
- By:
- Publication type:
- Article
MAZ-mediated up-regulation of BCKDK reprograms glucose metabolism and promotes growth by regulating glucose-6-phosphate dehydrogenase stability in triple-negative breast cancer.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 7, p. 1, doi. 10.1038/s41419-024-06835-y
- By:
- Publication type:
- Article
Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article